Sherif Farag discusses the clinical trial to test whether sitagliptin plus tacrolimus and sirolimus would reduce the incidence of grade II to IV acute GVHD from 30% to no more than 15% by day 100
Read the Study
Image courtesy of interviewee. October 12, 2021